Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
- Conditions
- Colorectal CancerPancreatic Cancer
- Registration Number
- NCT05400408
- Lead Sponsor
- Scentech Medical Technologies Ltd
- Brief Summary
Detection of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
- Detailed Description
A diagnostic prospective study with no anticipated risks or constraints. Main Objective: To quantify differences in exhaled breath VOCs of patients with colorectal or pancreatic cancers compared with cohorts without cancer.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 250
- Age 18 to 85 years at the time of consent.
- Scheduled for colonoscopy or Endoscopic Retrograde Cholangio Pancreatography.
- Fasted >6 hours, consuming water only.
- Able to provide informed written consent.
- Lacks capacity or is unable to provide informed written consent.
- Pregnant or lactating woman.
- Histologically confirmed cancer in any organ.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method identification of Volatile Organic Compounds that can be related to Colorectal malignancy. Through the study completion, up to 1 year. Comparison of identity and concentration of Volatile Organic Compounds profile found among colorectal patients and the identity and concentration of Volatile Organic Compounds profile found among Healthy controls.
- Secondary Outcome Measures
Name Time Method Test Sensitivity and specificity for colorectal polyps. Through the study completion, up to 1 year. Comparison of Volatile Organic Compounds found among subjects with and without colorectal polyps.
Test Sensitivity and specificity for pancreatic cancer. Through the study completion, up to 1 year. Comparison of Volatile Organic Compounds found among pancreatic patients and Healthy controls.
Trial Locations
- Locations (1)
Shamir Medical Center
🇮🇱Be'er Ya'aqov, Israel
Shamir Medical Center🇮🇱Be'er Ya'aqov, IsraelHaim Shirin, MDPrincipal Investigator